154 related articles for article (PubMed ID: 28117399)
1. Treatment effects of lysozyme-shelled microbubbles and ultrasound in inflammatory skin disease.
Liao AH; Hung CR; Lin CF; Lin YC; Chen HK
Sci Rep; 2017 Jan; 7():41325. PubMed ID: 28117399
[TBL] [Abstract][Full Text] [Related]
2. Compare ultrasound-mediated heating and cavitation between flowing polymer- and lipid-shelled microbubbles during focused ultrasound exposures.
Zhang S; Zong Y; Wan M; Yu X; Fu Q; Ding T; Zhou F; Wang S
J Acoust Soc Am; 2012 Jun; 131(6):4845-55. PubMed ID: 22712955
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.
Ryu S; Park Y; Kim B; Cho SM; Lee J; Lee HH; Gurley C; Song K; Johnson A; Armstrong CA; Song PI
Br J Dermatol; 2014 Dec; 171(6):1358-67. PubMed ID: 25313444
[TBL] [Abstract][Full Text] [Related]
4. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
5. Inverse effects of flowing phase-shift nanodroplets and lipid-shelled microbubbles on subsequent cavitation during focused ultrasound exposures.
Zhang S; Cui Z; Xu T; Liu P; Li D; Shang S; Xu R; Zong Y; Niu G; Wang S; He X; Wan M
Ultrason Sonochem; 2017 Jan; 34():400-409. PubMed ID: 27773262
[TBL] [Abstract][Full Text] [Related]
6. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
[TBL] [Abstract][Full Text] [Related]
7. In-vitro sonothrombolysis using thick-shelled polymer microbubbles - a comparison with thin-shelled microbubbles.
Janjic J; Larsson MK; Bjällmark A
Cardiovasc Ultrasound; 2020 May; 18(1):12. PubMed ID: 32366318
[TBL] [Abstract][Full Text] [Related]
8. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
Leyden JJ; Del Rosso JQ; Webster GF
Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of Euphorbia supina on Propionibacterium acnes-induced skin inflammation in vitro and in vivo.
Lim HJ; Jeon YD; Kang SH; Shin MK; Lee KM; Jung SE; Cha JY; Lee HY; Kim BR; Hwang SW; Lee JH; Sugita T; Cho O; Myung H; Jin JS; Lee YM
BMC Complement Altern Med; 2018 Sep; 18(1):263. PubMed ID: 30261862
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial and anti-inflammatory properties of nostocionone isolated from Nostoc commune Vauch and its derivatives against Propionibacterium acnes.
Itoh T; Tsuchida A; Muramatsu Y; Ninomiya M; Ando M; Tsukamasa Y; Koketsu M
Anaerobe; 2014 Jun; 27():56-63. PubMed ID: 24699048
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of bee venom on Propionibacterium acnes-induced inflammatory skin disease in an animal model.
An HJ; Lee WR; Kim KH; Kim JY; Lee SJ; Han SM; Lee KG; Lee CK; Park KK
Int J Mol Med; 2014 Nov; 34(5):1341-8. PubMed ID: 25215662
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Mediated EGF-Coated-Microbubble Cavitation in Dressings for Wound-Healing Applications.
Liao AH; Hung CR; Chen HK; Chiang CP
Sci Rep; 2018 May; 8(1):8327. PubMed ID: 29844469
[TBL] [Abstract][Full Text] [Related]
13. Control of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme.
Cebrián R; Arévalo S; Rubiño S; Arias-Santiago S; Rojo MD; Montalbán-López M; Martínez-Bueno M; Valdivia E; Maqueda M
Sci Rep; 2018 Aug; 8(1):11766. PubMed ID: 30082920
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
Abdel Fattah NS; Darwish YW
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
[TBL] [Abstract][Full Text] [Related]
15. Acne: a new model of immune-mediated chronic inflammatory skin disease.
Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
[TBL] [Abstract][Full Text] [Related]
16. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.
Huang WC; Tsai TH; Chuang LT; Li YY; Zouboulis CC; Tsai PJ
J Dermatol Sci; 2014 Mar; 73(3):232-40. PubMed ID: 24284257
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the physical properties of ultrasonically synthesized lysozyme- and BSA-shelled microbubbles.
Vong F; Son Y; Bhuiyan S; Zhou M; Cavalieri F; Ashokkumar M
Ultrason Sonochem; 2014 Jan; 21(1):23-8. PubMed ID: 23735894
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
Unno M; Cho O; Sugita T
Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 18F-labeled targeted perfluorocarbon-filled albumin microbubbles as a probe for microUS and microPET in tumor-bearing mice.
Liao AH; Wu SY; Wang HE; Weng CH; Wu MF; Li PC
Ultrasonics; 2013 Feb; 53(2):320-7. PubMed ID: 22832082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
